# Tesaro a GSK Company – FDA Inspection, May 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/tesaro-a-gsk-company/714e9037-e425-43d8-b4c2-23a9380c69a5
Source feed: FDA_Inspections

> FDA inspection 1123818 of Tesaro a GSK Company, May 12, 2020. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123818
- Company Name: Tesaro a GSK Company
- Inspection Date: 2020-05-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1101895 - 2019-07-16
- FDA Inspection 999778 - 2017-01-20
- FDA Inspection 924618 - 2015-04-01

Company: https://www.keypedia.com/companies/tesaro-a-gsk-company/f7d6b5b7-3b08-43dc-bed4-ea9f7d324858

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c